Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study

Rose Achim; El-Leithy Tarek; vom Dorp Frank; Zakaria Ahmed; Eisenhardt Andreas; Tschirdewahn Stephan; Ruebben Herbert

首页> 外文期刊>The Journal of Urology >Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study

【24h】

Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study

机译：槲寄生植物提取物在非肌肉浸润性膀胱癌患者中的作用：Ib / IIa期单剂量剂量递增研究的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: We determined the maximum tolerated dose, safety and effectiveness of intravesical instillation of mistletoe extract after transurethral resection of nonmuscle invasive bladder cancer.

机译：目的：我们确定了非肌肉浸润性膀胱癌经尿道切除术后槲寄生提取物膀胱内滴注的最大耐受剂量，安全性和有效性。

著录项

来源
《The Journal of Urology》 |2015年第4期|共5页
作者
Rose Achim; El-Leithy Tarek; vom Dorp Frank; Zakaria Ahmed; Eisenhardt Andreas; Tschirdewahn Stephan; Ruebben Herbert;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
urinary bladder neoplasms; mistletoe; abnoba viscum; administration; intravesical; treatment outcome;

机译：膀胱肿瘤;槲寄生;阿诺巴粘液;给药;膀胱内;治疗结果;
入库时间 2022-08-19 15:17:49

相似文献

外文文献
中文文献
专利

1. Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study [J] . Rose Achim, El-Leithy Tarek, vom Dorp Frank, The Journal of Urology . 2015,第4期

机译：槲寄生植物提取物在非肌肉浸润性膀胱癌患者中的作用：Ib / IIa期单剂量剂量递增研究的结果
2. Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study [J] . Rose Achim, El-Leithy Tarek, vom Dorp Frank, The Journal of Urology . 2015,第4期

机译：槲寄生植物提取物在非肌肉浸润性膀胱癌患者中的作用：Ib / IIa期单剂量剂量递增研究的结果
3. Mistletoe plant extract in patients with non muscle-invasive bladder cancer - results from a phase Ib/IIa single group dose escalation study [J] . Eisenbraun Juergen Phytomedicine : . 2015,第Suppla1期

机译：非肌肉浸润性膀胱癌患者的槲寄生植物提取物-Ib / IIa期单组剂量递增研究的结果
4. Brachytherapy Treatment Planning and Linac for Dose Measurement of Bladder and Rectum in Cervical Cancer Patients [C] . Suryani Dyah Astuti, Gege Ayu Listya, Nurul Fitriyah, International Seminar on Sensors, Instrumentation, Measurement and Metrology . 2018

机译：宫颈癌患者膀胱和直肠剂量的近距离治疗治疗计划和直线加速器
5. Cystoscopy and the development of invasive bladder cancer in patients presenting with superficial urinary bladder cancer. [D] . Amos, Charles E., Jr. 2003

机译：膀胱镜检查和浅表性膀胱癌患者的浸润性膀胱癌的发展。
6. Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer [O] . Roman Huber, Dietrich Schlodder, Carola Effertz, 2017

机译：静脉注射槲寄生提取物的安全性–晚期癌症患者I期剂量递增研究的结果
7. Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial▿ [O] . Santin, Alessandro D., Bellone, Stefania, Palmieri, Michela, 2007

机译：IB期或IIA期宫颈癌患者的人乳头瘤病毒16型和18型E7脉冲树突状细胞疫苗接种：I期递增剂量试验▿

Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study

摘要

著录项

相似文献

相关主题

期刊订阅